Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 49.66B | 49.14B | 49.05B | 44.81B | 39.35B | 35.59B |
Gross Profit | 13.20B | 13.17B | 12.73B | 10.41B | 9.89B | 8.76B |
EBITDA | 5.46B | 5.09B | 5.31B | 3.23B | 3.17B | 7.57B |
Net Income | 2.64B | 2.46B | 2.55B | 1.17B | 1.14B | 4.22B |
Balance Sheet | ||||||
Total Assets | 70.91B | 70.17B | 72.39B | 69.56B | 68.42B | 69.41B |
Cash, Cash Equivalents and Short-Term Investments | 8.26B | 8.93B | 8.78B | 7.01B | 6.79B | 7.67B |
Total Debt | 10.99B | 10.65B | 13.57B | 14.96B | 16.22B | 17.86B |
Total Liabilities | 30.93B | 29.60B | 34.09B | 34.49B | 34.42B | 36.45B |
Stockholders Equity | 39.23B | 39.84B | 37.62B | 34.46B | 33.41B | 32.41B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 3.87B | 3.42B | 1.59B | 1.02B | -805.00M |
Operating Cash Flow | 0.00 | 4.65B | 4.17B | 2.67B | 2.07B | 2.76B |
Investing Cash Flow | 0.00 | -815.00M | -580.00M | -821.00M | -917.00M | 3.30B |
Financing Cash Flow | 0.00 | -3.75B | -1.88B | -1.67B | -2.13B | -2.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
86 Outperform | ¥30.72B | 12.50 | 4.56% | 0.19% | -3.57% | ||
80 Outperform | ¥35.44B | 11.14 | 2.02% | 1.88% | 8.88% | ||
77 Outperform | ¥25.93B | 14.75 | 5.12% | 1.57% | 20.22% | ||
76 Outperform | ¥173.22B | 12.88 | 2.38% | 10.09% | 33.99% | ||
72 Outperform | $2.65T | 39.63 | 29.51% | 0.63% | 20.34% | 52.96% | |
67 Neutral | ¥252.05B | 13.25 | 6.48% | 2.75% | 5.05% | -11.93% | |
64 Neutral | ¥7.72B | 11.04 | 2.89% | -0.73% | 63.91% |